Live Breaking News & Updates on Hiddo Lambers Heerspink

Stay updated with breaking news from Hiddo lambers heerspink. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zibotentan, Dapagliflozin Combo Further Reduces Albuminuria in CKD

ZENITH-CKD is the first randomized trial comparing combined SGLT2 and endothelin A inhibition in patients with chronic kidney disease. Endothelin system blockade with zibotentan is a potential new therapy in chronic kidney disease (CKD). ....

City Of , United Kingdom , United States , Hiddo Lambers Heerspink , Gavin Brian Chapman , Neeraj Dhaun , American Society Of Nephrology Kidney Week , University Of Edinburgh , University Medical Center Groningen , American Society , Kidney Week ,

Zibotentan, Dapagliflozin Combo Further Reduces Albuminuria in CKD

ZENITH-CKD is the first randomized trial comparing combined SGLT2 and endothelin A inhibition in patients with chronic kidney disease. Endothelin system blockade with zibotentan is a potential new therapy in chronic kidney disease (CKD). ....

City Of , United Kingdom , United States , Gavin Brian Chapman , Hiddo Lambers Heerspink , Neeraj Dhaun , University Of Edinburgh , University Medical Center Groningen , American Society Of Nephrology Kidney Week , American Society , Kidney Week ,